AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Imunon, Inc. Director's Dealing 2022

Oct 3, 2022

35124_dirs_2022-10-03_77519b86-f653-4966-b7a6-4afc50c2cf69.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2022-09-29

Reporting Person: Dentzer James E (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct